Soluble <scp>CD163</scp> Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
Sara Konstantin Nissen(Aarhus University), Marina Romero‐Ramos(Aarhus University), Kathrin Brockmann(Oregon Health & Science University), Sara A. Ferreira(Aarhus University), Anne Panhelainen(University of Helsinki), Kalpana Shrivastava(Aarhus University), Anders Etzerodt(Aarhus University), Jonas Heilskov Graversen(University of Southern Denmark), Holger Jon Møller(Aarhus University), Walter Maetzler(Centre Hospitalier Universitaire de Lille), Dorle Hennig(University of Southern Denmark), Marlene Christina Nielsen(Aarhus University Hospital), Claudia Schulte(School of the Art Institute of Chicago), Daniela Berg(Christian-Albrechts-Universität zu Kiel)
Cited by 59
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846